Interphone: Microwave News Article Archive (2004 - )

It has been nearly eight years since an expert panel of the International Agency for Research on Cancer (IARC) classified RF radiation as a possible human carcinogen. Since then, neither the World Health Organization (WHO) nor the International Commission on Non-Ionizing Radiation Protection (ICNIRP) has recommended precautionary policies to limit potential health risks.

No U.S. health agency has yet advised the public to reduce RF exposures.

Even after two large animal studies —by the U.S. National Toxicology Program (NTP) and Italy’s Ramazzini Institute— presented clear evidence of a cancer link last year, the WHO has remained silent; ICNIRP responded by calling both animal studies unconvincing.

Now comes the Annual Review of Public Health, which on January 11 posted a paper by five leading epidemiologists who posit that, after a systematic review of all the human studies, they don’t see an elevated cancer risk. The takeaway is that the IARC classification was a mistake.

“Investigation of Bias Related to Differences Between Case and Control Interview Dates in Five Interphone Countries,” Annals of Epidemiology, December 2016.

This new analysis found “generally similar results” to the original Interphone study, but with “stronger positive associations among long-term users.”

“The Intracranial Distribution of Gliomas in Relation to Exposure from Mobile Phones: Analysis from the Interphone Study,” American Journal of Epidemiology, posted online November 3, 2016.

The latest analysis from Interphone. The same tensions continue with no clear consensus.

Power-frequency magnetic fields can promote brain tumors, according to the largest epidemiological study of its kind ever undertaken. The study promises to breathe new life into the idea that extremely low frequency (ELF) EMFs are more likely to be cancer promoters than causes of cancer. This hypothesis gained support a generation ago but has lost currency in recent years.

The new results, published online earlier this month by the journal Cancer Epidemiology, Biomarkers & Prevention, come from INTEROCC, an international project with seven participating countries designed to investigate occupational health risks from chemicals and EMFs. The project is directed by Elisabeth Cardis at CREAL in Barcelona with $1.5 million from the U.S. National Institutes of Health (though none of the tumor cases are from the U.S.).

The INTEROCC team found that those who were exposed to elevated EMF exposures at work during the five years prior to diagnosis had significantly higher rates of glioma compared to those who were least exposed during that time on the job. The greater the exposure, the greater the tumor risk.

“Interference Between Active Implanted Medical Devices and Electromagnetic Field Emitting Devices is Rare but Real: Results of an Incidence Study in a Population of Physicians in France,” PACE, posted online Spetmber 13, 2013, by Martine Hours and coworkers.

“Although minor, the risk of interference … is real and calls for vigilance. It particularly concerns antitheft and airport security gates…” Hours was a member of the French Interphone group.

The International Agency for Research on Cancer (IARC) has released its detailed evaluation of the cancer risks associated with RF radiation, which serves as the rationale for designating RF as a possible human carcinogen.

The IARC monograph comes close to two years after an invited panel of experts from 14 countries reached this conclusion following an eight-day meeting at IARC headquarters in Lyon, France (see our...

IARC has closed the book on the Interphone project, its study of mobile phone tumor risks. A couple of days ago, the cancer agency quietly issued a final report, stating that its work "has now been formally completed." The report, though dated October 3, 2011, was released on March 16th.

The International Agency for Research on Cancer (IARC) is playing some strange games, which will inevitably lead to more public confusion about cell phone cancer risks.

A few days ago, IARC issued some “Questions & Answers” on mobile phones and cancer prompted by last week's release of a new update of the Danish cohort study in the British Medical Journal (BMJ). (We’ll have much more to say about the Danish study in a later post.)

The Interphone results on acoustic neuroma (AN) are —finally— out. As in the Interphone analysis of brain tumors, there does appear to be a higher risk among the heaviest users of cell phones. Yet, as before, the results are uncertain and open to alternative explanations.